55
Growth Score in past quarter
pts
Heat Score 55 in past quarter
-25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2741173
Novel kits for assessing women with a high risk of developing pregnancy complications.
About the Company
Promyco Diagnostics has developed a simple and non-invasive serology diagnostic kit for the detection of urogenital Mycoplasma infection, thus assessing women at risk of developing pregnancy complications. Unique characteristics of the bacteria, mainly antigenic variation, make it hard to develop an efficient serology diagnostic test. Promyco
Diagnostics has overcome this obstacle and has developed a new assay based on an innovative and patent-protected mixture of mycoplasmal components (antigens). This antigen cocktail was carefully selected from Mycoplasmas isolated from patients with active inflammation, thus resulting in the first highly sensitive and specific serology test.